Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Doug Baer who wrote (23519)	7/25/1998 2:38:00 PM
From: Peter Singleton	Respond to of 32384

Doug, I doubt AGN's sales have anything to do with a judgement about LGND. They're probably done by the Treasury Department. There's no reason why AGN should hold LGND shares as part of their asset portfolio ... and I wouldn't expect them to. They're no longer part of a strategic partnership, and AGN's asset management folks are not chartered with investing in speculative, though high payback potential, biotech stocks. As far as I know, LGND has no plans for any equity offerings in the near or intermediate term. Part to avoid dilution, especially at these levels, and partly because their cash and committed funding levels should be sufficient for that period of time. Peter